STEVEN SUTHERLAND: Open Payments
NPI 1720098213 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$32,557 in 128 payments from 18 companies in 2025. Trend: 2023 $23,792 · 2024 $20,893 · 2025 $32,557
Honoraria: $26,475Travel & lodging: $3,044Food & beverage: $3,038
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 56 | $30,494 |
| Vanda Pharmaceuticals Inc. | 9 | $408 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $317 |
| Axsome Therapeutics, Inc. | 5 | $282 |
| Otsuka America Pharmaceutical, Inc. | 11 | $207 |
| Alkermes, Inc. | 5 | $134 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $123 |
| Collegium Pharmaceutical, Inc. | 5 | $121 |
| Janssen Pharmaceuticals, Inc | 4 | $98 |
| E.R. Squibb & Sons, L.L.C. | 4 | $97 |
Products named: Qelbree, FANAPT, CAPLYTA, Auvelity, REXULTI, ARISTADA, TRINTELLIX, Jornay PM.
Industry payments across NC — which companies pay providers there.
